Update: Kyntra Bio Q3 Adj. EPS $(3.42) Beats $(3.55) Estimate, Sales $1.762M Miss $1.766M Estimate
Benzinga Newsdesk 2 days ago
NewsEarningsEarnings BeatsEarnings Misses
This page contains a summary, not the full article. Continue to benzinga.com to read the original report.
Kyntra Bio (NASDAQ:KYNB) reported quarterly losses of $(3.42) per share which beat the analyst consensus estimate of $(3.55) by 3.66 percent. This is a 5.23 percent decrease over losses of $(3.25) per share from the
Kyntra Bio (NASDAQ:KYNB) reported quarterly losses of $(3.42) per share which beat the analyst consensus estimate of $(3.55) by 3.66 percent. This is a 5.23 percent decrease over losses of $(3.25) per share from the same period last year. The company reported quarterly sales of $1.762 million which missed the analyst consensus estimate of $1.766 million by 0.23 percent. This is a 63.75 percent increase over sales of $1.076 million the same period last year.
